Provided by Tiger Trade Technology Pte. Ltd.

BioCardia

1.27
-0.0100-0.78%
Pre-market: 1.280.0112+0.88%08:35 EST
Volume:93.21K
Turnover:118.24K
Market Cap:13.48M
PE:-0.77
High:1.38
Open:1.27
Low:1.22
Close:1.28
52wk High:3.20
52wk Low:1.00
Shares:10.61M
Float Shares:4.05M
Volume Ratio:1.54
T/O Rate:2.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6599
EPS(LYR):-2.8960
ROE:-317.47%
ROA:-86.45%
PB:5.13
PE(LYR):-0.44

Loading ...

BioCardia CEO Peter Altman Reports Disposal of Common Shares

Reuters
·
14 hours ago

BioCardia Cell Therapy for Ischemic Heart Failure to Progress to Formal Clinical Consultation with Japan PMDA

GlobeNewswire
·
Dec 16

BioCardia Inc. Files Initial Beneficial Ownership Statement for Director Marvin Slosman

Reuters
·
Dec 11

BRIEF-Biocardia Announces Election Of New Board Director

Reuters
·
Dec 03

BioCardia Appoints Marvin Slosman to Board as Richard Krasno Departs

Reuters
·
Dec 03

Press Release: BioCardia Announces Election of New Board Director, Marvin Slosman and Completion of Term for Outgoing Director, Dr. Richard Krasno

Dow Jones
·
Dec 03

BioCardia to Present at December 2025 CSI Focus Devices in Heart Failure Congress

GlobeNewswire
·
Dec 01

BioCardia Appoints New VP of Quality

TIPRANKS
·
Nov 25

BioCardia Strengthens Leadership Team With the Addition of Farhan Shahab as Vice President of Quality

THOMSON REUTERS
·
Nov 24

Press Release: BioCardia Strengthens Leadership Team with The Addition of Farhan Shahab as Vice President of Quality

Dow Jones
·
Nov 24

BioCardia, Inc. Q3 Net Income USD -1.483 Million

Reuters
·
Nov 20

BioCardia’s Earnings Call: Progress Amid Financial Challenges

TIPRANKS
·
Nov 14

BioCardia’s Q3 2025: Clinical Progress and Financial Stability

TIPRANKS
·
Nov 13

Cellular therapy developer BioCardia's Q3 net loss narrows

Reuters
·
Nov 13

BRIEF-BioCardia, Inc. Q3 Net Income USD -1.483 Million

Reuters
·
Nov 13

BioCardia, Inc. Q3 Operating Income USD -1.488 Million

THOMSON REUTERS
·
Nov 13

BioCardia, Inc. Q3 Basic EPS USD -0.24

THOMSON REUTERS
·
Nov 13

BioCardia Reports Third Quarter 2025 Business Highlights and Financial Results

GlobeNewswire
·
Nov 13

BioCardia reports Q3 net loss of $1.5 million on increased R&D expenses

Reuters
·
Nov 13

BioCardia Q3 EPS $(0.24) Beats $(0.25) Estimate

Benzinga
·
Nov 13